VERQUVO

Опис товару

About VERQUVO

VERQUVO is a prescription medication containing the active ingredient VERICIGUAT, indicated for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF) in adults. It works by activating soluble guanylate cyclase, leading to increased levels of cyclic guanosine monophosphate (cGMP) and subsequent vasodilation.

Key Benefits & Uses

• Treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF) in adults
• Improvement in exercise tolerance and reduction in hospitalization due to worsening heart failure
• Management of symptoms associated with heart failure, such as shortness of breath and fatigue

Active Ingredient & Action

VERICIGUAT, the active ingredient in VERQUVO, is a stimulator of soluble guanylate cyclase. It binds to the enzyme, activating it and leading to an increase in the production of cyclic guanosine monophosphate (cGMP). Elevated cGMP levels result in vasodilation, which helps to reduce the workload on the heart and improve cardiac function.

Important Notes

VERQUVO is available only by prescription and should be used under the guidance of a healthcare professional. Patients with a history of angioedema or hypersensitivity to VERICIGUAT should not take VERQUVO. Common side effects include dizziness, headache, and fatigue. Patients should report any unusual symptoms or concerns to their healthcare provider.